Deubiquitylating enzymes and drug discovery: emerging opportunities

被引：545

作者：

Harrigan, Jeanine A. ^{[1
]}

Jacq, Xavier ^{[1
]}

Martin, Niall M. ^{[1
,2
]}

Jackson, Stephen P. ^{[1
,3
,4
,5
]}

机构：

[1] Mission Therapeut Ltd, Babraham Res Campus, Cambridge CB22 3AT, England

[2] Artios Pharmaceut Ltd, Babraham Res Campus, Cambridge CB22 3AT, England

[3] Univ Cambridge, Wellcome Trust, Tennis Court Rd, Cambridge CB2 1QN, England

[4] Univ Cambridge, Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England

[5] Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QN, England

来源：

NATURE REVIEWS DRUG DISCOVERY | 2018年 / 17卷 / 01期

基金：

英国惠康基金;

关键词：

NF-KAPPA-B; UBIQUITIN-SPECIFIC PROTEASE; SMALL-MOLECULE INHIBITOR; GERMLINE BAP1 MUTATIONS; DNA-DAMAGE RESPONSE; C-TERMINAL HYDROLASE-L1; ANEURYSMAL BONE-CYST; PAPAIN-LIKE PROTEASE; PEPTIDASE; 11; USP11; GENE-PRODUCT; 9.5;

D O I：

10.1038/nrd.2017.152

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

More than a decade after a Nobel Prize was awarded for the discovery of the ubiquitin-proteasome system and clinical approval of proteasome and ubiquitin E3 ligase inhibitors, first-generation deubiquitylating enzyme (DUB) inhibitors are now approaching clinical trials. However, although our knowledge of the physiological and pathophysiological roles of DUBs has evolved tremendously, the clinical development of selective DUB inhibitors has been challenging. In this Review, we discuss these issues and highlight recent advances in our understanding of DUB enzymology and biology as well as technological improvements that have contributed to the current interest in DUBs as therapeutic targets in diseases ranging from oncology to neurodegeneration.

引用

页码：57 / 77

页数：21

共 302 条

[1] Ubiquitin-mediated activation of TAK1 and IKK [J].

Adhikari, A. ;

Xu, M. ;

Chen, Z. J. .

ONCOGENE, 2007, 26 (22) :3214-3226

[2] Usp16 contributes to somatic stem-cell defects in Down's syndrome [J].

Adorno, Maddalena ;

Sikandar, Shaheen ;

Mitra, Siddhartha S. ;

Kuo, Angera ;

Di Robilant, Benedetta Nicolis ;

Haro-Acosta, Veronica ;

Ouadah, Youcef ;

Quarta, Marco ;

Rodriguez, Jacqueline ;

Qian, Dalong ;

Reddy, Vadiyala M. ;

Cheshier, Samuel ;

Garner, Craig C. ;

Clarke, Michael F. .

NATURE, 2013, 501 (7467) :380-+

[3] Significance of PGP9.5 Expression in Cancer-Associated Fibroblasts for Prognosis of Colorectal Carcinoma [J].

Akishima-Fukasawa, Yuri ;

Ino, Yoshinori ;

Nakanishi, Yukihiro ;

Miura, Ayaka ;

Moriya, Yoshihiro ;

Kondo, Tadashi ;

Kanai, Yae ;

Hirohashi, Setsuo .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (01) :71-79

[4] Deubiquitinase Usp8 regulates α-synuclein clearance and modifies its toxicity in Lewy body disease [J].

Alexopoulou, Zoi ;

Lang, Johannes ;

Perrett, Rebecca M. ;

Elschami, Myriam ;

Hurry, Madeleine E. D. ;

Kim, Hyoung Tae ;

Mazaraki, Dimitra ;

Szabo, Aron ;

Kessler, Benedikt M. ;

Goldberg, Alfred Lewis ;

Ansorge, Olaf ;

Fulga, Tudor A. ;

Tofaris, George K. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (32) :E4688-E4697

[5] Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes [J].

Altun, Mikael ;

Kramer, Holger B. ;

Willems, Lianne I. ;

McDermott, Jeffrey L. ;

Leach, Craig A. ;

Goldenberg, Seth J. ;

Kumar, K. G. Suresh ;

Konietzny, Rebecca ;

Fischer, Roman ;

Kogan, Edward ;

Mackeen, Mukram M. ;

McGouran, Joanna ;

Khoronenkova, Svetlana V. ;

Parsons, Jason L. ;

Dianov, Grigory L. ;

Nicholson, Benjamin ;

Kessler, Benedikt M. .

CHEMISTRY & BIOLOGY, 2011, 18 (11) :1401-1412

[6] UBPY-mediated epidermal growth factor receptor (EGFR) de-ubiquitination promotes EGFR degradation [J].

Alwan, Husam A. J. ;

van Leeuwen, Jeroen E. M. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (03) :1658-1669

[7] Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma [J].

Annunziata, Christina M. ;

Davis, R. Eric ;

Demchenko, Yulia ;

Bellamy, William ;

Gabrea, Ana ;

Zhan, Fenghuang ;

Lenz, Georg ;

Hanamura, Ichiro ;

Wright, George ;

Xiao, Wenming ;

Dave, Sandeep ;

Hurt, Elaine M. ;

Tan, Bruce ;

Zhao, Hong ;

Stephens, Owen ;

Santra, Madhumita ;

Williams, David R. ;

Dang, Lenny ;

Barlogie, Bart ;

Shaughnessy, John D., Jr. ;

Kuehl, W. Michael ;

Staudt, Louis M. .

CANCER CELL, 2007, 12 (02) :115-130

[8] Identification by functional proteomics of a deubiquitinating/deNeddylating enzyme in Plasmodium falciparum [J].

Artavanis-Tsakonas, Katerina ;

Misaghi, Shahram ;

Comeaux, Christy A. ;

Catic, Andre ;

Spooner, Eric ;

Duraisingh, Manoj T. ;

Ploegh, Hidde L. .

MOLECULAR MICROBIOLOGY, 2006, 61 (05) :1187-1195

[9] Characterization and Structural Studies of the Plasmodium falciparum Ubiquitin and Nedd8 Hydrolase UCHL3 [J].

Artavanis-Tsakonas, Katerina ;

Weihofen, Wilhelm A. ;

Antos, John M. ;

Coleman, Bradley I. ;

Comeaux, Christy A. ;

Duraisingh, Manoj T. ;

Gaudet, Rachelle ;

Ploegh, Hidde L. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (09) :6857-6866

[10] Crystal Structure of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Papain-like Protease Bound to Ubiquitin Facilitates Targeted Disruption of Deubiquitinating Activity to Demonstrate Its Role in Innate Immune Suppression [J].

Bailey-Elkin, Ben A. ;

Knaap, Robert C. M. ;

Johnson, Garrett G. ;

Dalebout, Tim J. ;

Ninaber, Dennis K. ;

van Kasteren, Puck B. ;

Bredenbeek, Peter J. ;

Snijder, Eric J. ;

Kikkert, Marjolein ;

Mark, Brian L. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (50) :34667-34682

← 1 2 3 4 5 6 7 8 9 10 →